A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC

Clinical trial NCT07521852 · RECRUITING

Trial details

NCT number: NCT07521852
Sponsor: TaiRx, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HCC - Hepatocellular Carcinoma

Start date: 2026-03-31
Primary completion: 2027-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.